STARTUP PROFILE

Optohive

COUNTRY
Switzerland
FOUNDED
2024
CATEGORY
Neuroimaging
Offering wearable fNIRS brain imaging (HiveOne + AI software) for real-time, high-precision neural monitoring in clinical and research settings.
Visit website →
Neurofounders Insights
$   Funding   -
Non-dilutive
MODALITY
fNIRS
FORM FACTOR
Headset/cap
INTERFACE DEPTH
Non-invasive
INDICATION
General brain health
TARGET USER
Researchers
REGULATORY STAGE
Research only
Optohive is positioned in next-generation wearable fNIRS, pairing hardware with AI software for real-time neural monitoring in research and possible clinical contexts. It remains early and research-oriented, but technically aligned with the trend toward lighter portable hemodynamic sensing.
Mentioned in Market Notes
MOST RECENT COVERAGE
#
8
FDA Supports the BCI Mission
18 August – 1 September 2026

Optohive made its HiveOne wearable fNIRS system commercially available to researchers. The ETH Zürich spin-out's headset uses functional near-infrared spectroscopy, an optical method that measures brain activity through changes in blood oxygenation, paired with proprietary silicon photomultiplier sensors to deliver lab-grade data in a lightweight, fully wireless form. It is built for real-world settings that traditional imaging cannot easily reach. Beyond research, Optohive is developing the platform toward longitudinal brain monitoring for conditions such as ADHD and stroke rehabilitation.

Articles featuring
Optohive
No items found.